Theranos, the troubled blood testing startup, is facing a criminal investigation into whether it misled investors.
The startup which is valued at $9 billion, has come under fire after reports found irregularities with its tests.
The company is currently under a criminal problem and a civil from from the SEC, according to several reports from The Wall Street Journal.
In recent weeks both Theranos partner Walgreens and the New York State Department of Health have received subpoenas. Those requests were issued to seek documents and other information about the representations that Theranos made, according to the WSJ.
Bloomberg also reports that the US Attorney’s Office for the Northern District of California is leading one of the probes.
It’s been a touch 7 months for Theranos which first started to come unraveled in October 2015 when The Wall Street Journal questioned the accuracy of the company’s tests.
The current criminal investigation is still in its early stages with subpoenas being issued to determine if prosecutors can move forward with an indictment.
CEO Elizabeth Holmes said this week she is “devastated” that the Federal government is trying to ban her from her own company for a period of two years.